ZA200706061B - Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma - Google Patents

Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma Download PDF

Info

Publication number
ZA200706061B
ZA200706061B ZA200706061A ZA200706061A ZA200706061B ZA 200706061 B ZA200706061 B ZA 200706061B ZA 200706061 A ZA200706061 A ZA 200706061A ZA 200706061 A ZA200706061 A ZA 200706061A ZA 200706061 B ZA200706061 B ZA 200706061B
Authority
ZA
South Africa
Prior art keywords
hydrogen
residue
completely
nitro group
aliphatic
Prior art date
Application number
ZA200706061A
Other languages
English (en)
Inventor
Hoffmann Hans-Rainer
Matusch Rudolf
Baniahmad Aria
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA200706061B publication Critical patent/ZA200706061B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA200706061A 2005-02-05 2007-07-17 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma ZA200706061B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005005397A DE102005005397B4 (de) 2005-02-05 2005-02-05 Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms

Publications (1)

Publication Number Publication Date
ZA200706061B true ZA200706061B (en) 2008-07-30

Family

ID=36129940

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706061A ZA200706061B (en) 2005-02-05 2007-07-17 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma

Country Status (12)

Country Link
US (1) US7700654B2 (enExample)
EP (1) EP1845963A2 (enExample)
JP (1) JP5191238B2 (enExample)
KR (1) KR20070100844A (enExample)
CN (1) CN101111240B (enExample)
AU (1) AU2006210040B9 (enExample)
BR (1) BRPI0606563A2 (enExample)
CA (1) CA2596618C (enExample)
DE (1) DE102005005397B4 (enExample)
MX (1) MX2007009402A (enExample)
WO (1) WO2006081994A2 (enExample)
ZA (1) ZA200706061B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2734215B1 (en) * 2011-07-22 2019-06-05 Goel, Pawan Kumar Improved process for pygeum extraction
US20130085283A1 (en) * 2011-10-04 2013-04-04 Coyote Pharmaceuticals, Inc. Geranylgeranylacetone derivatives
WO2013157926A1 (en) * 2012-04-19 2013-10-24 Nyken Holding B.V. Geranyl geranyl acetone analogs and uses thereof
CN104892470B (zh) * 2015-06-11 2017-04-12 嘉兴学院 制备n‑烷基对甲苯磺酰胺的方法
US9782370B2 (en) * 2015-12-21 2017-10-10 Gongwin Biopharm Holdings Co., Ltd. Pharmaceutical compositions of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518075A (en) * 1963-01-28 1970-06-30 Stauffer Chemical Co Method of controlling weeds
JPS5829784B2 (ja) * 1975-08-22 1983-06-24 萬有製薬株式会社 オメガ − （ アリ−ルスルホンアミド ）− アルキルアミンノ セイホウ
DE2948186A1 (de) * 1979-11-30 1981-07-23 Henkel KGaA, 4000 Düsseldorf Neue sulfonamide, ihre herstellung und ihre verwendung als antimikrobielle substanzen
CA1241967A (en) * 1984-05-11 1988-09-13 George C. Buzby Jr. Sulfonamides useful as anti-arrhythmic agents
HU208113B (en) * 1987-08-20 1993-08-30 Smith Kline French Lab Process for producing sulfonamide derivatives and pharmaceutical compositions comprising same as active ingredient
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
JPH02266351A (ja) * 1989-04-06 1990-10-31 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料の処理方法
ES2125468T3 (es) * 1993-08-16 1999-03-01 Meiji Seika Kaisha Derivado de sulfonilsemicarbazida y composicion para mantener la frescura de las flores cortadas.
ATE169298T1 (de) * 1994-03-28 1998-08-15 Pfizer Benzisothiazol-derivate als inhibitoren der 5- lipoxygenase biosynthese
US5891454A (en) * 1997-03-28 1999-04-06 Alexander Wu Anti-cancer drug and special tumor necrotizing agent
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6121252A (en) * 1998-03-30 2000-09-19 Guilford Pharmaceuticals Inc. Phosphinic acid derivatives
JP2000338660A (ja) * 1999-05-27 2000-12-08 Toray Ind Inc ポジ型電子線レジスト組成物およびこれを用いたレジストパターンの製造法
CA2318004A1 (en) * 1999-09-15 2001-03-15 Oridigm Corporation Novel polyamine analogues as therapeutic and diagnostic agents
CA2422767A1 (en) * 1999-10-22 2001-04-22 Glaxo Group Limited In vivo imaging
US6727287B2 (en) * 2001-04-16 2004-04-27 Pts International, Inc. Toluene sulfonamide-containing anti-tumor composition and method of use thereof
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
ATE291413T1 (de) * 2003-07-17 2005-04-15 3M Espe Ag Dentalzusammensetzungen mit ethyleniminverbindungen und nicht-reaktiven beschleunigern
US7576206B2 (en) * 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7223745B2 (en) * 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
TW200600091A (en) * 2004-05-21 2006-01-01 Telik Inc Sulfonylethyl phosphorodiamidates
AR050552A1 (es) * 2004-09-02 2006-11-01 Osi Pharm Inc Mercaptoamidas como inhibidores de histona desacetilasa

Also Published As

Publication number Publication date
WO2006081994A2 (de) 2006-08-10
JP5191238B2 (ja) 2013-05-08
WO2006081994A3 (de) 2007-03-22
JP2008528647A (ja) 2008-07-31
AU2006210040B2 (en) 2011-04-14
MX2007009402A (es) 2007-09-25
US7700654B2 (en) 2010-04-20
CN101111240B (zh) 2011-09-21
DE102005005397B4 (de) 2008-08-21
BRPI0606563A2 (pt) 2009-11-17
CA2596618A1 (en) 2006-08-10
DE102005005397A1 (de) 2006-08-10
US20080177107A1 (en) 2008-07-24
CN101111240A (zh) 2008-01-23
CA2596618C (en) 2013-05-07
AU2006210040A1 (en) 2006-08-10
AU2006210040B9 (en) 2011-05-26
EP1845963A2 (de) 2007-10-24
KR20070100844A (ko) 2007-10-11

Similar Documents

Publication Publication Date Title
Belemtougri et al. Effects of two medicinal plants Psidium guajava L.(Myrtaceae) and Diospyros mespiliformis L.(Ebenaceae) leaf extracts on rat skeletal muscle cells in primary culture
Sonar et al. Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase
ZA200706061B (en) Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma
ZA200706107B (en) Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy
CN102697821B (zh) 荒漠寄生植物锁阳的综合利用方法及其产物和它们的应用
RU2174982C2 (ru) 3,28-ди-о-никотинат бетулина, проявляющий гепатопротекторную и анти-вич активность
PL195797B1 (pl) Pochodne hiperforynowe, kompozycje farmaceutyczneje zawierające i zastosowanie tych pochodnych
Mangathayaru et al. Estrogenic effect of Erythrina variegata L. in prepubertal female rats
Gololo et al. Isolation of a mixture of Phytosterol compounds from the n-Hexane extract of Jatropha lagarinthoides (Sond) collected from Zebediela sub-region in Limpopo province
Rajkumara et al. Isolation of Chemical Constituents from Mimusops elengi bark and Evaluation of Anti-inflammatory activity
Wu 5, 7, 20-O-Trimethylsilybins as Anti-Prostate Cancer Agents
RU2679310C1 (ru) Способ получения средства, обладающего гастропротективной, противовоспалительной, антиоксидантной активностью
Ahmadi Synthesis, characterization and anti-inflammatory evaluation of novel derivatives of Trolox with pharmacological alcohol and amines
Taka et al. Acidified water extraction increases carpaine yield from Carica papaya L. Leaf
Konsowa et al. Amr M. Abo-Elhamd2, Ahmed M. Aboul-Enein1, Samy M. Mohamed2, Ahmed S. Shalaby2
CN106727564A (zh) Atropurpuran的哌嗪基和二羟乙胺基衍生物组合物用于防治肾纤维化